---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-012329"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T11:22:26.022133+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Immunovant files prospectus supplement to register 5.65M shares for resale by selling stockholders

## Summary
- Filed prospectus supplement to register up to 5,654,990 shares of common stock for resale by selling stockholders.
- Shares were acquired by selling stockholders in private placement financing reported on January 13, 2025.
- Opinion of counsel Cooley LLP regarding legality of shares filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001193125-25-012329
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000119312525012329/0001193125-25-012329-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000119312525012329/d920756d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-012329
- JSON: https://secwatch.observer/filing/0001193125-25-012329.json
- Plain text: https://secwatch.observer/filing/0001193125-25-012329.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.